Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac To Supply Beijing with Seasonal Flu Vaccine

publication date: Aug 28, 2009

Sinovac Biotech (北京科兴生物制品有限公司) has been selected by the Public Health Bureau of Beijing to be one of four vaccine companies that will supply the city with seasonal flu vaccine for 2009. Sinovac will provide Beijing with its split viron vaccine, Anflu®. The city hopes the vaccine’s usefulness will spread beyond the seasonal flu to also protect its citizens from H1N1 swine flu. Sinovac did not disclose financial terms or its share of the contract. More details...

Stock Symbol: (NYSE: SVA)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here